CONTEXT: Dr. Joanne Kurtzberg, Dr. James M. Provenzale, and colleagues at Duke University prospectively evaluated diffusion-tensor MRI (DTI) anisotropy measurements of white matter regions in Krabbe disease patients treated with stem cell transplantation, a promising new therapeutic approach for a condition that previously had no cure. They compared anisotropy values in infants who underwent stem cell transplantation in the first month of life (before development of clinical signs of Krabbe disease) with those who had the procedure after development of clinical signs of the disease at approximately six months of age.
RESULTS: Anisotropy values in all patients were compared with those of five age-matched normal children with no neurologic disease. Anisotropy values in the early-treatment group were near normal at the time of transplantation and were substantially higher than anisotropy values at the time of transplantation in the late-treatment group (which ranged from 55% to 74% of normal). Over the next two years, anisotropy values remained at 80% to 90% of normal values in the early-transplant group but decreased to 36% to 39% of normal in the late-transplant group. Early-transplant children had mild or moderate neurologic disability, whereas late-transplant children had severe neurologic disability.
IMAGE: Fractional anisotropy values appear in the posterior limb of the internal capsule in the image (left). They correspond (right) with abnormal signal in the same region. (Provided by J. Provenzale. Reprinted from Radiology 2005;236[1]:221-230)
IMPLICATIONS: Good concordance was seen between the DTI values and clinical outcome. The results indicate that DTI might be a useful means of assessing disease progression in Krabbe disease and other white matter disorders. Maintenance of anisotropy values in the mildly or moderately decreased range in children who underwent early transplantation probably represents amelioration of the disease process in this demyelinating condition.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
May 29th 2025Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.